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Phytochemical investigation of the aerial parts ofGymnema sylvestre has led to the isolation of seven
new triterpenes, six oleane types (5, 7 – 11) and a new lupane type (12), and of the six known analogues
1 – 4, 6, and 13. The structures and relative configurations of these compounds were elucidated by
spectroscopic analyses, including 1D- and 2D-NMR spectroscopy and mass spectrometry, and by the
comparison of their NMR data with those of related compounds.
Introduction. –Gymnema sylvestre is a bushy climber of the Asclepiadaceae family
that is found mainly in the Central and Tropical Indian Peninsula, Sri Lanka, and
Africa. It is considered a medicinal plant and is used in folk medicine, ayurveda, and
homeopathy for treatment of asthma, eye disorders, inflammation, and snake bites, as a
tonic and refrigerant, diuretic, laxative, sedative for coughs, and especially as an
antidote for diabetes [1]. Recent studies, based on the historical evidence of the many
uses in the medicinal field, have indicated that the leaves and roots of the plant are the
parts that contain the biologically active ingredients [2]. The active compounds of G.
sylvestre are called gymnemic acids [3]. Their use in the past to counteract the effects of
excess glucose in diabetes mellitus explains the Hindi name of the plant, Gur-ma
which means destroyer of sugar. The plant extracts have been reported to exert an
antimicrobial and hepatoprotective activity, and to lower the levels of triglycerides and
LDL cholesterol, and raise the HDL cholesterol (good cholesterol) [4] [5]. They also
act as a deterrent against Prodenia eridania, prevent dental caries caused by
Streptococcus mutans, and are used in skin cosmetics [6 – 8].
In an investigation of G. sylvestre, we have isolated five known oleanane-type
triterpenes, 1 – 4 and 6, six new analogs, 5 and 7 – 11, and two lupane-type triterpenes, 12
and 13, the former of which was new.
Results and Discussion. – The CH2Cl2 extract of the aerial parts of G. sylvestre was
separated into acidic and neutral fractions with 2n NaOH. The neutral fraction, washed
with H2O and concentrated under reduced pressure, was filtered through SiO2 with
petroleum ether, CH2Cl2, AcOEt, Me2CO, MeOH, and H2O, as eluents of increasing
polarity. Column chromatography of the fraction eluted with CH2Cl2 yielded
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compounds 1 – 13. The known triterpenes 1 – 4, 6, and 13 were identified as 3b,16b,28-
trihydroxyolean-12-ene (1) [9], 3b,16b,21b,28-tetrahydroxyolean-12-ene (2) [10],
3b,16b,22a,28-tetrahydroxyolean-12-ene (3) [11], 3b,23,28-trihydroxyolean-12-ene
(4) [12], 3b,16b,21b,23,28-pentahydroxyolean-12-ene (6) [13], and 3b,16b,29-trihy-
droxylup-20(30)-ene (13) [14].
The new compounds were characterized by various spectroscopic methods. The
ESI-MS of compound 5 showed a quasi-molecular-ion peak at m/z 475.2 ([MþH]þ),
suggesting the molecular formula C30H50O4 and six degrees of unsaturation. Fragment
ions atm/z 457.5 ([MH2OþH]þ), 439.3 ([M 2 H2OþH]þ), and retro-DielsAlder
fragmentation ion, characteristic of an oleanane skeleton, at m/z 250.4 (50%)
evidenced an olean-12-ene derivative. The 1H- and 13C-NMR spectra of 5 confirmed
this assumption. The 1H-NMR spectrum showed signals of five H-atoms geminal to an
O-bearing function as three double doublets at d(H) 4.10, 3.61, 3.52, a doublet at 3.53,
and a signal at d(H) 3.31, partly obscured by solvent. The 13C-NMR spectrum (Table)
exhibited signals of three O-bearing CH groups at d(C) 74.5, 74.3, 67.8 and of a O-
bearing CH2 group at d(C) 67.8. In the upfield region of 1H-NMR, seven Me singlets
were detected at d(H) 1.23, 1.02, 1.01, 0.95, 0.87, 0.81, and 0.71. The analysis of COSY,
NOESY, HSQC, and HMBC spectra allowed us to determine the structure of
3b,16b,21b,23-tetrahydroxyolean-12-ene for this compound. The 1H,1H-COSY experi-
ment showed correlations between HC(16) (d(H) 4.10) and CH2(15) (d(H) 1.67 and
1.25); HC(21) (d(H) 3.52) and CH2(22) (d(H) 1.68 and 1.60); and HC(3) (d(H)
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3.61) and CH2(2) (d(H) 1.96 and 1.93). The latter correlated with the CH2(1) (d(H)
1.65, 1.16). Finally, the signal of the olefinic H-atom HC(12) at d(H) 5.28 correlated
with HC(11) (d(H) 1.96 and 1.93). The correlations in the HMBC experiment
between the H-atom signal at d(H) 4.10 and that of the H-atoms of Me(28) at d(H)
0.81 with the CH signal at d(C) 50.5, assigned to C(18) and bonded to H-atom with the
signal at d(H) 2.20, and between the signal of HC(18) with that of the O-bearing
HC(16) at d(C) 67.8, indicated an OH group at C(16). The correlations between the
signals of HC(23) at d(H) 3.53 and 3.31 with that of the CH at d(C) 48.5, assigned to
C(5) and bonded to the H-atom with the signal at d(H) 1.62, and between this signal
and that of the O-bearing CH2 at d(H) 67.8 localized another OH group at C(23).
Finally, the correlations of the signals of two geminal Me groups, i.e., Me(29) at d(H)
0.95 and Me(30) at d(H) 0.87, with the C-atom signal at d(C) 74.5 defined a further
hydroxylation site at C(21). These data, compared with those of the other isolated
triterpenes, were in accordance with a 3,16,21,23-tetrahydroxyoleanane skeleton. The
Helvetica Chimica Acta – Vol. 96 (2013)1038
Table. 13C-NMR Data of Triterpenes 5, 7 – 12 (at 125 MHz, in CD3OD; d in ppm)
C-Atom 5 7 8 9 10 11 12
C(1) 40.1 40.1 40.2 39.4 39.1 39.3 40.2
C(2) 25.1 27.9 28.1 37.1 37.5 37.1 28.1
C(3) 74.3 74.3 74.4 219.2 220.1 218.8 74.2
C(4) 43.8 43.7 42.6 51.6 53.9 54.0 43.9
C(5) 48.5 49.3 49.0 (obs)a) 48.7 47.2 47.3 49.4
C(6) 19.6 19.6 19.7 21.0 20.9 21.0 19.5
C(7) 33.9 34.0 36.3 33.5 33.4 33.4 35.4
C(8) 43.8 41.3 43.9 38.0 41.4 41.8 43.9
C(9) 49.0 48.7 52.1 47.4 48.6 48.5 51.9
C(10) 37.7 37.6 38.7 40.0 41.4 37.7 38.6
C(11) 25.1 25.1 23.9 25.3 25.2 25.3 22.4
C(12) 124.5 124.7 27.0 124.4 124.8 125.6 26.7
C(13) 142.3 144.5 139.9 145.2 143.7 142.2 38.5
C(14) 45.2 45.3 48.0 42.2 45.2 44.2 46.2
C(15) 37.0 36.6 37.3 37.1 36.9 36.5 39.0
C(16) 67.8 71.7 78.2 68.3 68.9 69.8 80.0
C(17) 40.1 45.3 45.1 41.8 45.2 47.5 46.2
C(18) 50.5 44.6 129.8 45.6 44.6 43.3 49.8
C(19) 41.6 43.8 40.3 48.1 48.6 47.8 49.6
C(20) 38.2 36.5 34.2 32.2 37.7 37.8 151.6
C(21) 74.5 76.2 36.0 35.3 74.4 78.7 31.5
C(22) 28.8 33.1 30.7 26.6 34.2 74.4 33.9
C(23) 67.8 67.8 67.9 68.5 68.3 69.4 67.7
C(24) 13.2 13.2 13.1 18.5 18.3 18.5 13.0
C(25) 17.0 17.0 17.8 16.4 16.3 16.3 17.5
C(26) 18.1 18.0 19.0 17.8 17.7 17.8 17.7
C(27) 28.1 27.3 23.2 27.9 27.7 28.1 16.8
C(28) 22.9 68.1 64.5 69.5 68.4 59.6 62.4
C(29) 30.3 28.2 32.9 31.8 30.1 30.6 111.1
C(30) 18.3 26.0 25.8 24.8 18.0 19.2 19.9
a) obs: Obscured by the solvent.
configurations of the OH groups were deduced from a NOESY experiment (Fig.),
where HC(16) showed NOE effects with the H-atoms of Me(27) and H-atom
HC(19) (d(H) 2.10), indicating a b-orientation for the OH group at C(16). The
HC(21) showed NOE effects with the H-atoms of Me(29), HC(19), and HC(16)
indicating also a b-orientation for the OH group at C(21).
The ESI-MS of compound 7 showed a quasi-molecular-ion peak atm/z 491.4 ([Mþ
H]þ), suggesting the molecular formula C30H50O5 and six degrees of unsaturation.
Fragment-ion peaks at m/z 473.4 ([MH2OþH]þ), 455.3 ([M 2 H2OþH]þ), and
retro-DielsAlder fragmentation-ion peak, characteristic of an oleanane skeleton, atm/
z 267.5 (30%) evidenced an olean-12-ene derivative. The 1H- and 13C-NMR data were
similar to those of triterpene 6, whose structure had been previously reported in [13]. A
concise analysis of its spectroscopic data allowed us to determine the structure of 7 as
the C(21)-epimer of the reference compound 6. The 1H,1H-COSY experiment showed
correlations between: the double doublet HC(16) at d(H) 4.57 and the CH2(15) at
d(H) 1.80 and 1.30, the broad triplet HC(21) at d(H) 3.52 and the CH2(22) at d(H)
2.14 and 1.77, abd the double doublet HC(3) at d(H) 3.62 and the CH2(2) at d(H)
1.71. The correlations in the HMBC experiment between the two geminal Me(29)
and Me(30) at d(H) 0.92 and 0.95, respectively, with C-atom at d(C) 76.2 indicated
a hydroxylation site at C(21). The configuration at this C-atom has been defined
by a NOE experiment where HC(21) showed NOE effects with both Me(29) and
Me(30), indicating an a-orientation of the OH group. This assumption was supported
by the multiplicity of HC(21) signal, which appeared as a broad triplet at 3.52 (J¼
3.0).
The ESI-MS of compound 8 displayed a quasi-molecular-ion peak at m/z 475.5
([MþH]þ), indicating the molecular formula C30H50O4 with six degrees of unsatura-
tion. Fragment-ion peaks at m/z 457.3 ([MH2OþH]þ), 439.2 ([M 2 H2OþH]þ)
were also detected. The 1H-NMR spectrum showed signals of six geminal H-atoms
bound to an oxygenated function (two as double doublets at d(H) 3.72 and 3.62, and
three as doublets at d(H) 3.82, 3.76, and 3.54, and one at d(H) 3.30, obscured by the
solvent). In the upfield region, six Me singlets were evident at d(H) 1.26, 0.96, 2 0.92,
0.76, and 0.68. The 13C-NMR (Table) showed two O-bearing CH signals at d(C) 78.2
and 74.4, and those of two O-bearing CH2 groups at d(C) 67.9 and 64.5. The presence of
two sp2 quaternary C-atoms (d(C) 139.9 and 129.8) indicated a C(13)¼C(18) bond.
Analysis of COSY, NOESY, HSQC, and HMBC spectra allowed us to determine the
structure of 3b,16b,23,28-tetrahydroxyolean-13,18-ene for this compound. This pro-
posal was confirmed by the HMBC of Me(27) with the downfield olefinic C(13) and
correlations of HC(16) and CH2(28) with the upfield olefinic C(18). The 1H,1H-
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Figure. Key NOE correlations for compound 5
COSY experiment showed correlations between HC(16) (d(H) 3.72) and CH2(15)
(d(H) 1.98 and 1.35); and HC(3) (d(H) 3.62) and CH2(2) (d(H) 1.63). The latter
correlated with CH2(1) (d(H) 1.71 and 1.05). Finally, H-atoms CH2(12) (d(H) 2.72 and
1.89) correlated with CH2(11) (d(H) 1.27) that correlated with HC(9) (d(H) 1.59).
The correlations in the HMBC experiment between CH2(23) (d(H) 3.54 and 3.30) with
the C-atom with a signal at d(C) 49.0, assigned to C(5) and bonded to H-atom with the
signal at d(H) 1.18, and between this H-atom with the C-atom with the signal at d(C)
74.4 evidenced a OH group at the C(23) position. In the NOESY experiment, the
HC(16) showed NOE effects with Me(27) and H-atomHaC(22), strongly suggesting
a b-orientation for the OH group; moreover, one of the H-atoms Me(28) (d(H) 3.82)
showed a NOE with Me(26) (d(H) 0.92), HC(12) (d(H) 2.72) showed a NOE effect
with CH2(19) (d(H) 2.35), and this latter gave NOEs with Me(29) and Me(30) (d(H)
0.96 and 0.76, resp.). The structure of this triterpene was reported some time ago by
Shibata et al. [15] as a hydrogenation product of saikogenin A.
The ESI-MS of compound 9 showed a quasi-molecular-ion peak atm/z 473.2 ([Mþ
H]þ), suggesting the molecular formula C30H48O4 and seven degrees of unsaturation.
Fragment-ion peaks at m/z 455.2 ([MH2OþH]þ), as well as an absorption band at
3376 cm1 in the IR spectrum indicated the presence of OH groups. The retro-
DielsAlder fragmentation-ion peak, characteristic of the oleane skeleton, in particular
the positively charged D/E ring-fragment peak at m/z 249.1 (42%) and the less
abundant, positively charged A/B ring-fragment peak at m/z 225.4 (6%) evidenced an
olean-12-ene derivative. The IR spectrum also showed absorption bands at 1118, 1090,
and 1045 cm1, consistent with the presence of HOC groups, and a band at 1722 cm1
for the presence of a CO group. The 13C-NMR (Table) spectrum showed 30 signals,
which with the DEPT experiment, revealed the presence of six Me groups (d(C) 31.8,
27.9, 24.8, 18.5, 17.8, and 16.4), an olefinic C-atom (d(C) 124.4), an O-bearing CH group
(d(C) 68.3), and two O-bearing CH2 groups (d(C) 69.5 and 68.5). The 1H-NMR
spectrum indicated six tertiary Me groups (d(H) 1.28, 1.11, 1.07, 0.98, and 2 0.93), an
O-bearing CH group as double doublet (d(H) 4.28), two O-bearing CH2 groups (two
doublets at d(H) 3.87 and 3.63), and it exhibited two signals (d(H) 3.29 and 3.38),
obscured by the solvent, and a trisubstituted olefinic H-atom signal at d(H) 5.29
attributed to HC(12). Analysis of COSY, NOESY, HSQC, and HMBC spectra
allowed us to deduce the structure of 16b,23,28-trihydroxyolean-12-en-3-one for this
compound. The 1H,1H-COSY experiment showed correlations between: HC(16)
(d(H) 4.28) and CH2(15) (d(H) 1.88 and 1.43); CH2(2) (d(H) 2.48 and 2.40) and the
CH2(1) (d(H) 1.88 and 1.50); and the olefinic H-atom HC(12) and CH2(11) (d(H)
1.98). The correlations, in the HMBC experiment, between the H-atoms with the
signals at d(H) 3.63 and 3.38 with the CH group at d(C) 48.7, assigned to C(5) and
bonded to H-atom with a signal at d(H) 1.99, and between this latter H-atom with the
O-bearing CH (d(C) 68.5) localized an OH group at C(23). Additionally, the HMBCs
between the H-atoms resonating at d(H) 3.63 and 3.38; and Me(26) (d(H) 0.93) with
the CO (d(C) 219.2); evidencing the C(3)¼O group and identifying the Me(23)
group; and those between the H-atom with a signal at d(H) 2.22, bonded to CH,
resonating at d(C) 45.6 and assigned to C(18), with the O-bearing CH with a signal at
d(C) 68.3 indicated an OH group at C(28). The configuration of the OH group at C(16)
was delineated by a NOESY experiment, showing NOEs between HC(16) (d(H)
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4.28) and Me(27) (d(H) 1.28) and HC(19), indicating a b-orientation for the OH
group.
The ESI-MS of compound 10 showed a quasi-molecular-ion peak at m/z 489.2
([MþH]þ), suggesting the molecular formula C30H48O5 and seven degrees of
unsaturation. Fragment-ion peaks at m/z 471.3 ([MH2OþH]þ), 453.1 ([M
2 H2OþH]þ), and a retro-DielsAlder fragmentation-ion peak at m/z 267.2 (20%)
were characteristic for an olean-12-ene derivative. The IR spectrum showed absorption
bands at 3350, 1118, 1090, and 1045 cm1, consistent with the presence of a OH and
COC groups, and a band of a CO group at 1724 cm1. The 13C-NMR spectrum
(Table) displayed 30 signals, which, with the DEPTexperiment, revealed the presence
of six Me groups (d(C) 30.1, 27.7, 18.3, 18.0, 17.7, and 16.3), an olefinic C-atom (d(C)
124.8), two O-bearing CH groups (d(C) 74.4 and 68.9), and two O-bearing CH2 groups
(d(C) 68.4 and 68.3). The 1H-NMR spectrum revealed the presence of six tertiary Me
(d(H) 0.89, 0.93, 0.96, 1.07, 1.10, and 1.28), two O-bearing CH groups (double doublets
at d(H) 4.20 and 3.55), two O-bearing CH2 groups (doublets at d(H) 3.60 and 3.78),
and it exhibited two signals obscured by the solvent (d(H) 3.30 and 3.32), and one
trisubstituted olefinic H-atom signal at d(H) 5.31 attributed to HC(12). Analysis of
COSY, NOESY, HSQC, and HMBC spectra allowed us to elucidate the structure of
16b,21b,23,28-tetrahydroxyolean-12-en-3-one for this compound. Many of the corre-
lations observed were similar to those of compound 9, indicating the same substitution
pattern in ringsA,B,C, andD. Another OH group was assigned to C(21) on the basis of
the HMBCs between Me(29) and Me(30) (d(H) 0.96 and 0.89, resp.) with the O-
bearing CH group resonating at d(C) 74.4, and between HC(21) (d(H) 3.55) and the
C-atoms resonating at d(C) 48.6 (C(19)), 45.2 (C(17)), 37.7 (C(20)), 30.1 (C(29)), and
18.0 (C(30)). The configuration of the OH group at C(21) has been determined by a
NOESY experiment, where the H-atom with a signal at d(H) 3.55 showed NOE with
Me(29) and HC(16) revealing a b-orientation for the OH group.
The ESI-MS of compound 11 exhibited a quasi-molecular-ion peak at m/z 505.3
([MþH]þ), suggesting the molecular formula C30H48O6 and seven degrees of
unsaturation. Fragment-ion peaks at m/z 487.2 ([MH2OþH]þ), 469.4 ([M
2 H2OþH]þ), and retro-DielsAlder fragmentation-ion peak at m/z 283.1 (20%)
evidenced an olean-12-ene derivative. The IR spectrum showed absorption bands at
3330, 1128, 1080, and 1050 cm1, consistent with the presence of OH and HOC groups,
and a band of a CO group at 1723 cm1. The 1H- and 13C-NMR spectra were consistent
with an olean-12-ene skeleton. The 13C-NMR spectrum (Table) displayed 30 signals,
which, with the DEPTexperiment, revealed the presence of six Me groups (d(C) 30.6,
28.1, 19.2, 18.5, 17.8, and 16.3), an olefinic C-atom (d(C) 125.6), three O-bearing CH
groups (d(C) 78.7, 74.4, and 69.8), and two O-bearing CH2 groups (d(C) 69.4 and 59.6).
The 1H-NMR spectrum revealed the presence of six tertiary Me (d(H) 1.30, 1.10, 1.08,
1.00, 0.93, and 0.92), three O-bearing CH groups (one as double doublet at d(H) 4.63)
and two as doublets at d(H) 3.98 and 3.52), two O-bearing CH2 groups (four doublets at
d(H) 3.92, 3.56 and 3.62, 3.36), and one trisubstituted olefinic H-atom (d(H) 5.40)
assigned as HC(12). Analysis of COSY, NOESY, HSQC, and HMBC spectra allowed
us to determine the structure of 16b,21b,22a,23,28-pentahydroxyolean-12-en-3-one for
this compound. Many of the correlations observed were similar to those of compound
10. The other OH group was assigned to C(22) on the basis of COSY that showed
Helvetica Chimica Acta – Vol. 96 (2013) 1041
correlation between HC(21) and HC(22) (d(H) 3.52 and 3.98, resp.), and the large
coupling constant of 11.0 Hz indicated their 1,2-trans relation. In the HMBC spectrum,
correlations between Me(30) (d(H) 0.92) and Me(29) (d(H) 1.00) with the O-bearing
HC(21) (d(C) 78.7); and between HC(21) and the C-atoms resonating at d(C) 74.4
(C(22)), 47.5 (C(17)), 30.6 (C(29)), and 19.2 (C(30)) were observed. Furthermore, the
O-bearing HC(22) correlated with C-atoms, resonating at d(C) 69.8, 59.6, and 43.3,
that were assigned to the C(16), C(28), and C(18), respectively. The configuration of
the OH groups was determined by a NOESY experiment, where the HC(21) showed
NOE with Me(29) and HC(16), indicating a b-orientation for the OH group, and
HC(22) showed NOE effects with the Me(30) and HC(18), revealing an a-
orientation for the OH group.
The ESI-MS of compound 12 showed a quasi-molecular-ion peak at m/z 475.1
([MþH]þ), suggesting the molecular formula C30H50O4 and six degrees of unsatura-
tion. Fragment-ion peaks at m/z 457.3 ([MH2OþH]þ) and 439.1 ([M 2 H2Oþ
H]þ) were also observed. The 13C-NMR spectrum (Table) showed 30 C-atom signals,
identified on the basis of a DEPT experiment as those for five Me, twelve CH2, seven
CH groups, and six quaternary C-atoms. The 1H-NMR data, together with those
derived from an HSQC experiment, evidenced the presence of two olefinic H-atoms
(d(H) 4.72 and 4.60), bonded to the C-atom resonating at d(C) 111.1, four H-atoms
(two doublets at d(H) 4.10 and 3.44, correlated to the C-atom resonating at d(C) 62.4,
and one as doublet at d(H) 3.52, and one at d(H) 3.29 obscured by solvent, correlated
to the C-atom resonating at d(C) 67.7), and, finally, two H-atoms (double doublets at
d(H) 3.73 and 3.58), assigned to the C-atoms resonating at d(C) 80.0 and 74.2,
respectively. In the upfield region, five Me singlets at d(H) 1.69, 1.11, 1.03, 0.90, and
0.68, correlated, in the HSQC, with the C-atom resonances at d(C) 19.9, 17.7, 16.8, 17.5,
and 13.0, respectively, were identified. The 1H,1H-COSY experiment showed the
following correlations: HC(3) (d(H) 3.58) with CH2(2) (d(H) 1.66 – 1.60), which
showed a cross-peak with CH2(1) (d(H) 1.68 – 1.63 and 0.95 – 0.89); HC(16) (d(H)
3.73) with CH2(15) (d(H) 1.82, 1.45 – 1.40); and HC(19) (multiplet at d(H) 2.50 – 2.45)
with HC(18) (d(H) 1.58 – 1.50) and CH2(21) (d(H) 2.05 – 2.02, 1.48 – 1.41). The
HMBC experiment furnished useful data to solve the structure. In fact, the sp2-C-atom
C(29) correlated with Me(30) (d(H) 1.69) and the HC(19) (d(H) 2.50 – 2.45). The H-
atoms of Me(30) were also correlated with the C-atoms resonating at d(C) 151.6
(C(20)) and 49.6 (C(19)), while HC(19) also displayed correlations with C-atoms, at
resonating d(C) 46.2, 33.9, and 19.9, assigned to C(17), C(22), and C(30), respectively.
Moreover HC(3) (d(H) 3.58) and CH2(23) (d(H) 3.52, 3.29), in the same HMBC
experiment, gave cross-peaks with C-atoms resonating at d(C) 49.4, 43.9, and 13.0,
assigned to C(5), C(4), and C(24), respectively. Finally, HC(16) (d(H) 3.73) and
CH2(28) (d(H) 4.10 and 3.44) gave cross-peaks with C(22) and those, resonating at
d(C) 49.8 and 46.2, assigned to C(18) and C(17), respectively. These data were in
accordance with a lupane triterpene structure. The relative configurations of the
stereogenic C-atoms were determined by a NOESY experiment. The H-atoms of
Me(27) showed NOE with the HC(16), indicating a b-configuration of the OH group.
These data allowed us to determine the structure of 3b,16b,23,28-tetrahydroxylup-
20(29)-ene for this compound.
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Experimental Part
General. Optical rotations: in MeOH or CH2Cl2; Perkin-Elmer 141 polarimeter. IR Spectra: Jasco
FT/IR430 instrument. HPLC: Shimadzu LC-10AD by using a refractive-index detector Shimadzu RID-
10A. Semiprep. HPLC: RP-18 (LiChrospher 10 mm, 250 10 mm i.d.;Merck) column with a flow rate of
1.2 ml min1. Column chromatography (CC): Merck Kieselgel 60 (SiO2; 230 – 400 mash). Prep. TLC:
silica gel (UV254 precoated) plates with 0.5- and 1.0-mm thickness (Merck). 1H- and 13C-NMR Spectra:
Varian INOVA-500 FT NMR spectrometer (1H at 499.710 and 13C at 125.663 MHz), in CDCl3 or CD3OD
solns., at 258, d in ppm, J in Hz. Proton-detected heteronuclear correlations were measured using a
gradient heteronuclear single-quantum coherence (HSQC), optimized for 1J(H,C)¼ 140 Hz, and a
gradient heteronuclear multiple bond coherence (HMBC), optimized for nJ(H,C)¼ 8 Hz.
Plant Material. Gymnema sylvestre was purchased fromMother Herbs Ltd. (13 Street, Madhu Vihar,
Patpadganj, Delhi – 110092, India, e-mail: info@motherherbs.com) and identified by Prof. Antonino
Pollio of the Dipartimento delle Scienze Biologiche of the University of Naples. A sample specimen
(HERBNAWY 124) has been deposited with the herbarium of the University Federico II.
Extraction and Isolation. Dried and finely powdered aerial parts of G. sylvestre (7.0 kg) were sliced
and extracted with H2O (25 l for 24 h) and successively with CH2Cl2 (20 l for 96 h). The org. extract was
filtered and evaporated in vacuo to remove CH2Cl2. The resulting extract (350 g) was fractionated into
acidic and neutral fractions with aq. 2nNaOH soln. The neutral soln., washed withH2O and concentrated
in vacuo (175 g), was subjected to CC (SiO2; with petroleum ether (PE), CH2Cl2, AcOEt, Me2CO,
MeOH, and H2O).
The fraction eluted with CH2Cl2 (25.0 g) was fractionated by CC (SiO2; CH2Cl2/MeOH 100 :0 to
0 :100).
The fractions eluted with CH2Cl2 (592 mg) were purified by flash CC (SiO2, and then the fractions
eluted with CH2Cl2/AcOEt 17 :3 (37 mg) were further purified by prep. TLC (CH2Cl2/Me2CO 17 :3) to
give triterpene 1 (5 mg).
The fractions eluted with CH2Cl2/MeOH 19 :1 (913 mg) were purified by CC (SiO2), and the
fractions eluted with CH2Cl2/MeOH 19 :1 (62 mg), were further purified by HPLC (RP-18 ; MeOH/
MeCN/H2O 2 :7 :1) to yield triterpenes 3, 4, 9, and 13 (2, 2, 15, and 2 mg, resp.).
The fractions eluted with CH2Cl2/MeOH 9 :1 (96 mg) were purified by HPLC (RP-18 ; MeOH/
MeCN/H2O 3 :4 :3) to yield triterpene 6 (36 mg).
The fractions eluted with CH2Cl2/MeOH 9 :1 (2.28 g) were purified by CC (SiO2), and then fractions
eluted with CH2Cl2/MeOH 4 :1 (291 mg) were purified by HPLC (RP-18 ; MeOH/MeCN/H2O 2 :2 :1) to
give triterpenes 8 and 12 (3 and 15 mg, resp.).
The fractions eluted with CH2Cl2/MeOH 1 :9 (6.38 g) were purified by flash CC (SiO2), and the
fractions eluted with Me2CO (611 mg) were purified by HPLC (RP-18 SepPak ; MeOH/MeCN/H2O
1 :2 :2) to give Frs. 1 – 6. Fr. 4 (60 mg) was purified HPLC (RP-18 ; MeOH/MeCN/H2O 2 :3 :5) to give
triterpene 11 (6 mg). Fr. 5 (127 mg) was purified by HPLC (RP-18 ; MeOH/MeCN/H2O 2 :5 :3) to give
triterpenes 2, 5, and 7 (43, 12, and 10 mg, resp.). Fr. 6 (25 mg) was purified by HPLC (RP-18 ; MeOH/
MeCN/H2O 2 :5 :3) to give triterpene 10 (22 mg).
3b,16b,21b,23-Tetrahydroxyolean-12-ene (¼ (3b,16b,21b)-Olean-12-ene-3,16,21,23-tetrol ; 5). Amor-
phous powder. [a]25D ¼þ20.5 (c¼ 0.27, MeOH). IR (film): 3347, 1130, 1080, 1035. 1H-NMR (CD3OD):
5.28 (br. s, HC(12)); 4.10 (dd, J¼ 11.7, 3.9, HC(16)); 3.61 (dd, J¼ 11.0, 4.4, HC(3)); 3.53 (d, J¼ 11.3,
HaC(23)); 3.52 (dd, J¼ 10.8, 4.2, HC(21)); 3.31 (obscured by solvent, HbC(23)); 2.20 (dd, J¼ 14.1,
3.8, HC(18)); 2.10 (br. d, J¼ 13.1, CH2(19)); 1.98 – 1.93 (m, CH2(2), CH2(11)); 1.70 – 1.60 (m, CH2(22));
1.71 – 1.56 (m, 1 H of CH2(7)); 1.69 – 1.59 (m, 1 H of CH2(15)); 1.69 – 1.61 (m, 1 H of CH2(1)); 1.65 – 1.59
(m, HC(5)); 1.50 – 1.42 (m, CH2(6)); 1.33 – 1.27 (m, 1 H of CH2(7)); 1.27 – 1.21 (m, 1 H of CH2(15)); 1.23
(s, Me(27)); 1.20 – 1.15 (m, HC(9)); 1.18 – 1.11 (m, 1 H of CH2(1)); 1.02 (s, Me(26)); 1.01 (s, Me(25));
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0.95 (s, Me(29)); 0.87 (s, Me(30)); 0.81 (s, Me(28)); 0.71 (s, Me(24)). 13C-NMR (CD3OD): see the Table.
ESI-MS: 475.2 ([MþH]þ). HR-ESI-MS: 475.3769 ([MþH]þ , C30H51Oþ4 ; calc. 475.3787).
3b,16b,21a,23,28-Pentahydroxyolean-12-ene (¼ (3b,16b,21a)-Olean-12-ene-3,16,21,23,28-pentol ; 7).
Amorphous powder. [a]25D ¼þ32.3 (c¼ 0.23, MeOH). IR (film): 3330, 1115, 1095, 1035. 1H-NMR
(CD3OD): 5.29 (br. s, HC(12)); 4.57 (dd, J¼ 11.7, 3.9, HC(16)); 3.74 (d, J¼ 10.8, HaC(28)); 3.62 (dd,
J¼ 11.0, 4.4, HC(3)); 3.54 (d, J¼ 11.3, HaC(23)); 3.52 (br. t, J¼ 3.0, HC(21)); 3.32 (obscured by
solvent, HbC(28), HbC(23)); 2.30 (dd, J¼ 14.1, 3.8, HC(18)); 2.17 (br. d, J¼ 13.1, CH2(19)); 2.16 –
2.10 (m, 1 H of CH2(22)); 1.99 – 1.94 (m, CH2(11)); 1.82 – 1.74 (m, 1 H of CH2(15)); 1.79 – 1.70 (m, 1 H
of CH2(22)); 1.73 – 1.67 (m, CH2(2)); 1.71 – 1.66 (m, 1 H of CH2(7)); 1.69 – 1.62 (m, 1 H of CH2(1)); 1.66 –
1.61 (m, HC(9)); 1.52 – 1.43 (m, 1 H of CH2(6)); 1.41 – 1.34 (m, 1 H of CH2(7)); 1.41 – 1.33 (m, 1 H of
CH2(6)); 1.33 – 1.25 (m, 1 H of CH2(15)); 1.26 (s, Me(27)); 1.22 – 1.15 (m, HC(5)); 1.05 – 1.00 (m, 1 H of
CH2(1)); 1.03 (s, Me(26)); 1.01 (s, Me(25)); 0.95 (s, Me(29)); 0.92 (s, Me(30)); 0.71 (s, Me(24)). 13C-NMR
(CD3OD): see the Table. ESI-MS: 491.4 ([MþH]þ). HR-ESI-MS: 491.3728 ([MþH]þ , C30H51Oþ5 ; calc.
491.3736).
3b,16b,23,28-Tetrahydroxyolean-13(18)-ene (¼ (3b,16b)-Olean-13(18)-ene-3,16,23,28-tetrol ; 8) .
Amorphous powder. [a]25D ¼1.2 (c¼ 0.19, MeOH). IR (film): 3334, 1112, 1087, 1034. 1H-NMR
(CD3OD): 3.82 (d, J¼ 11.4, HaC(28)); 3.76 (d, J¼ 11.4, HbC(28)); 3.72 (dd, J¼ 12.8, 4.1, HC(16));
3.62 (dd, J¼ 10.9, 4.9, HC(3)); 3.54 (d, J¼ 11.7, HaC(23)); 3.30 (obscured by solvent, HbC(23)); 2.72
(br. d, J¼ 15.0, 1 H of CH2(12)); 2.35 (d, J¼ 14.1, 1 H of CH2(19)); 2.33 – 2.28 (m, CH2(21)); 1.98 (br. t,
J¼ 12.8, HC(15)); 1.89 (br. t, J¼ 15.7, 1 H of CH2(12)); 1.73 – 1.66 (m, 1 H of CH2(1)); 1.68 – 1.63 (m,
HC(19)); 1.65 – 1.59 (m, CH2(2)); 1.65 – 1.56 (m, CH2(21)); 1.62 – 1.54 (m, HC(9)); 1.51 – 1.45 (m, 1 H
of CH2(6)); 1.38 – 1.33 (m, 1 H of CH2(6)); 1.37 – 1.30 (m, 1 H of CH2(15)); 1.27 (m, CH2(11)); 1.26 (s,
Me(27)); 1.24 (m, CH2(7)); 1.20 – 1.15 (m, HC(5)); 1.06 – 1.01 (m, 1 H of CH2(1)); 0.96 (s, Me(29)); 0.92
(s, Me(25), Me(26)); 0.76 (s, Me(30)); 0.68 (s, Me(24)). 13C-NMR (CD3OD): see the Table. ESI-MS:
475.5 ([MþH]þ). HR-ESI-MS: 475.3745 ([MþH]þ , C30H51Oþ4 ; calc. 475.3787).
16b,23,28-Trihydroxyolean-12-en-3-one (9). Amorphous powder. [a]25D ¼þ25.5 (c¼ 0.21, MeOH).
IR (film): 3376, 1722, 1118, 1090, 1045. 1H-NMR (CD3OD): 5.29 (br. s, HC(12)); 4.28 (dd, J¼ 12.0, 4.8,
HC(16)); 3.87 (d, J¼ 10.0, HaC(28)); 3.63 (d, J¼ 10.0, HaC(23)); 3.38 (obscured by solvent,
HbC(23)); 3.29 (oscured by solvent, HbC(28)); 2.49 – 2.40 (m, CH2(2)); 2.24 – 2.19 (m, HC(18));
2.18 – 2.12 (m, 1 H of CH2(22)); 2.02 – 1.75 (m, CH2(19)); 1.99 – 1.96 (m, HC(5)); 1.99 – 1.94 (m,
CH2(11)); 1.89 – 1.83 (m, 1 H of CH2(1)); 1.89 – 1.85 (m, 1 H of CH2(15)); 1.76 – 1.71 (m, 1 H of CH2(7));
1.77 – 1.72 (m, HC(9)); 1.52 – 1.45 (m, CH2(6)); 1.51 – 1.48 (m, 1 H of CH2(1)); 1.45 – 1.39 (m, 1 H of
CH2(22)); 1.45 – 1.38 (m, 1 H of CH2(21)); 1.44 – 1.40 (m, 1 H of CH2(15)); 1.43 – 1.39 (m, 1 H of CH2(7));
1.28 (s, Me(27)); 1.25 – 1.20 (m, 1 H of CH2(21)); 1.11 (s, Me(26)); 1.07 (s, Me(25)); 0.98 (s, Me(29)); 0.93
(s, Me(24), Me(30)). 13C-NMR (CD3OD): see the Table. ESI-MS: 473.2 ([MþH]þ). HR-ESI-MS:
473.3620 ([MþH]þ , C30H49Oþ4 ; calc. 473.3631).
16b,21b,23,28-Tetrahydroxyolean-12-en-3-one (10). Amorphous powder. [a]25D ¼þ26.5 (c¼ 0.22,
MeOH). IR (film): 3350, 1724, 1118, 1090, 1045. 1H-NMR (CD3OD): 5.31 (br. s, HC(12)); 4.20 (dd, J¼
11.7, 4.8, HC(16)); 3.78 (d, J¼ 10.8, HaC(28)); 3.60 (d, J¼ 10.8, HaC(23)); 3.55 (dd, J¼ 11.7, 3.90,
HC(21)); 3.32 (oscured by solvent, HbC(28)); 3.30 (oscured by solvent, HbC(23)); 2.33 – 2.27 (m,
HC(18)); 2.30 – 1.50 (m, CH2(22)); 2.00 (m, CH2(11)); 1.98 (br. d, J¼ 12.3, 1 H of CH2(15)); 1.92 – 1.86
(m, 1 H of CH2(1)); 1.89 – 1.75 (m, 1 H of CH2(7)); 1.88 – 1.82 (m, 1 H of CH2(2)); 1.88 – 1.80 (m,
HC(9)); 1.83 – 1.78 (m, 1 H of CH2(6)); 1.82 – 1.77 (m, 1 H of CH2(19)); 1.75 – 1.70 (m, HC(5)); 1.52 –
1.47 (m, 1 H of CH2(1)); 1.50 – 1.45 (m, 1 H of CH2(7)); 1.40 – 1.35 (m, 1 H of CH2(2)); 1.40 – 1.31 (m, 1 H
of CH2(6)); 1.33 – 1.28 (m, 1 H of CH2(19)); 1.28 (br. d, J¼ 12.3, 1 H of CH2(15)); 1.28 (s, Me(27)); 1.10 (s,
Me(26)); 1.07 (s, Me(25)); 0.96 (s, Me(29)); 0.93 (s, Me(24)); 0.89 (s, Me(30)). 13C-NMR (CD3OD): see
the Table. ESI-MS: 489.2 ([MþH]þ). HR-ESI-MS: 489.3563 ([MþH]þ , C30H49Oþ5 ; calc. 489.3580).
16b,21b,22a,23,28-Pentahydroxyolean-12-en-3-one (11). Amorphous powder. [a]25D ¼þ23.1 (c¼ 0.27,
MeOH). IR (film): 3330, 1723, 1128, 1080, 1050. 1H-NMR (CD3OD): 5.39 (t, J¼ 3.4, HC(12)); 4.63 (dd,
J¼ 11.6, 5.2, HC(16)); 3.98 (d, J¼ 11.0, HC(22)); 3.92 (d, J¼ 10.9, HaC(28)); 3.62 (d, J¼ 10.8,
HaC(23)); 3.56 (d, J¼ 10.9, HbC(28)); 3.52 (d, J¼ 11.0, HC(21)); 3.36 (d, J¼ 10.8, HbC(23)); 2.68
(dd, J¼ 14.2, 4.3, HC(18)); 2.50, 2.38 (2m, CH2(2)); 2.05 (m, 1 H of CH2(11)); 1.98 (m, HC(9)); 1.96
(m, 1 H of CH2(11)); 1.92 (m, 1 H of CH2(19)); 1.90, 1.50 (2m, CH2(1)); 1.77 (dd, J¼ 11.5, 6.1, HC(5));
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1.71 (m, 1 H of CH2(7)); 1.68 (br. d, J¼ 12.3, 1 H of CH2(15)); 1.48 (m, CH2(6)); 1.36 (br. d, J¼ 12.7, 1 H
of CH2(7)); 1.30 (s, Me(27)); 1.26 (m, 1 H, Me(15)); 1.20 (dd, J¼ 14.0, 4.5, 1 H of CH2(19)); 1.10 (s,
Me(26)); 1.08 (s, Me(25)); 1.00 (s, Me(29)); 0.93 (s, Me(24)); 0.92 (s, Me(30)). 13C-NMR (CD3OD): see
the Table. ESI-MS: 505.3 ([MþH]þ). HR-ESI-MS: 505.3500 ([MþH]þ , C30H49Oþ6 ; calc. 505.3529).
3b,16b,23,28-Tetrahydroxylup-20(29)-ene (¼ (3b,16b)-Lup-20(29)-ene-3,16,23,28-tetrol; 12). Amor-
phous powder. [a]25D ¼þ10.5 (c¼ 0.23, MeOH). IR (film): 3350, 1556, 1090, 1045. 1H-NMR (CD3OD):
4.72 (br. s, HC(29)); 4.60 (br. s, HC(29)); 4.10 (d, J¼ 11.5, HaC(28)); 3.73 (dd, J¼ 10.5, 5.0,
HC(16)); 3.58 (dd, J¼ 11.0, 5.0, HC(3)); 3.52 (d, J¼ 11.5, HaC(23)); 3.44 (d, J¼ 11.5, HbC(28));
3.29 (overlapped, HbC(23)); 2.50 – 2.45 (m, HC(19)); 2.37 (br. dd, J¼ 12.5, 7.9, 1 H of CH2(22)); 2.05 –
2.02 (m, 1 H of CH2(21)); 1.82 (br. t, J¼ 12.2, 1 H of CH2(15)); 1.69 (s, Me(30)); 1.71 – 1.63 (m, 1 H of
CH2(12)); 1.68 – 1.63 (m, 1 H of CH2(1)); 1.66 – 1.60 (m, CH2(2)); 1.59 – 1.40 (m, CH2(7)); 1.58 – 1.50 (m,
HC(18)); 1.48 – 1.41 (m, 1 H of CH2(21), CH2(6)); 1.46 – 1.23 (m, CH2(11)); 1.45 – 1.40 (m, 1 H of
CH2(15)); 1.38 – 1.31 (m, HC(9)); 1.22 – 1.17 (m, 1 H of CH2(22)); 1.11 (s, Me(26)); 1.12 – 1.07 (m,
HC(5)); 1.05 – 1.01 (m, 1 H of CH2(12)); 1.03 (s, Me(27)); 0.95 – 0.89 (m, 1 H of CH2(1)); 0.90 (s,
Me(25)); 0.68 (s, Me(24)). 13C-NMR (CD3OD): see the Table. ESI-MS: 475.1 ([MþH]þ). HR-ESI-MS:
475.3765 ([MþH]þ , C30H51Oþ4 ; calc. 475.3787).
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